HealthSnap has secured a $25 million senior secured growth financing facility led by Eastward Capital Partners to accelerate AI innovation, expand commercial operations, and scale deployment of its Advanced Primary Care Management platform.
The financing will also strengthen HealthSnap’s balance sheet and refinance existing debt. The company plans to invest additional capital in product development, engineering, customer success, and enterprise expansion.
HealthSnap operates an AI-powered virtual care management platform that combines Remote Patient Monitoring, Chronic Care Management, Principal Care Management, Advanced Primary Care Management, AI-powered clinical workflows, enterprise analytics, reimbursement optimization, and care coordination.
The company currently supports more than 80,000 active patient programs across 200 health systems and physician organizations and expects to exceed 100,000 active patient programs by the end of 2026. Its platform processes approximately two patient measurements every second.
HealthSnap’s customers include Prisma Health, AdventHealth, Ascension Health, Sentara Health, Tampa General Hospital, UnityPoint Health, Baptist Health South Florida, Mount Sinai Medical Center, and University Hospitals. Sentara, Tampa General, and UnityPoint have also made strategic investments in the company.
Earlier this year, HealthSnap launched an AI-augmented APCM solution combining agentic AI with clinical workflows. The company is using AI for clinical decision support, workforce training, patient engagement, enrollment, device troubleshooting, compliance outreach, and automated clinical summaries.
In 2025, HealthSnap’s AI platform reviewed more than 3 million progress notes. The company also uses AI-powered patient simulations to train nurses before they interact with patients. HealthSnap said all AI recommendations operate within clinician-defined protocols and safety guardrails, with clinicians retaining final decision-making authority.
HealthSnap has increased revenue more than fivefold over the past three years, representing more than 400% growth since June 2023. The company also reported 40% year-over-year revenue growth and a 47% year-over-year improvement in EBITDA.
HealthSnap cited clinical research associating its remote monitoring programs with improved blood pressure control, fewer hospitalizations and emergency department visits, and lower healthcare costs. One study involving more than 6,500 patients was associated with an average 7.3 mmHg reduction in systolic blood pressure, while another study reported a median annual total-care-cost reduction of $10,932 among high-acuity Medicare beneficiaries.
Ziegler served as HealthSnap’s exclusive financial advisor for the financing.
KEY QUOTES:
“When we founded HealthSnap, we believed healthcare was moving toward a future where continuous, intelligent care would become the standard, not the exception. Today, we are helping many of the nation’s leading health systems make that vision a reality. This financing represents much more than additional capital. It validates the platform we have built, the outcomes we are delivering, and the category leadership we have established.”
“Our vision has always been to use AI to amplify clinicians, not replace them, helping health systems improve outcomes, strengthen operational performance, and lower the total cost of care.”
Samson Magid, Co-Founder and CEO of HealthSnap
“Healthcare is entering a new era where artificial intelligence, automation, and continuous patient engagement will fundamentally reshape care delivery. We believe HealthSnap has established itself as the clear leader in this emerging category through exceptional execution, enterprise customer adoption, measurable outcomes, and a highly differentiated platform.”
Ed Dresner, Investment Partner at Eastward Capital Partners
